At the recent event 'The Briefing: AI for Science', Anthropic unveiled Claude Science, an AI workbench designed to consolidate fragmented scientific tools and datasets, enhancing the pace of scientific discovery and healthcare interventions. The company, which has established a strong presence in AI with its coding tools, announced plans to develop its own drugs, focusing on treatments for neglected diseases. This move positions Anthropic uniquely as it also sells software to competing drugmakers. While the AI drug discovery sector is rapidly evolving, Anthropic has yet to disclose specific details regarding its drug development strategies, potential disease targets, or partnerships for further research and clinical trials.
HealthcareAI drug discoveryClaude Science+1
HealthcareAI drug discoveryClaude ScienceBiotech
Anthropic Announces Plans to Develop Its Own Drugs with Claude Science AI Workbench
Hacker News· erhuve· Sunday, July 5, 2026
More Articles From This Day
AI InfrastructureInvestment+2
AI InfrastructureInvestmentMacronModi
Macron and Modi Lead Global AI Infrastructure Race with Strategic Tech CEO Engagement
French President Emmanuel Macron and Indian Prime Minister Narendra Modi are actively courting technology CEOs to secure significant investments in AI infrastructure. Macron recently negotiated a €75 billion data center deal with SoftBank, facilitated through personal text exchanges with founder Masayoshi Son. Modi, following a similar approach, secured a $48 billion commitment from Amazon's CEO Andy Jassy for AI and cloud infrastructure in India. These engagements highlight the importance of direct relationships between heads of state and tech leaders in driving substantial investments that will shape the future of AI systems. The recent Choose France Summit and the India AI Impact Summit have showcased the growing stakes in AI infrastructure development, with billions pledged for projects in both countries.